Dr David Warncken
MD (Flinders University), Bachelor of Medical Science (Flinders University), Graduate Diploma Addiction and Mental Health (Adelaide University).
Dr Warncken was promoted to the role of Director, Medical and Clinical Guidelines Research, at GENI during May 2024. He is a member of the Clinical Practice Guidelines (CPG) Development Sub-committee of GENI’s CPG Innovations Steering Committee. During 2024, he is undertaking research concerning CPG development practices in Australia, involving the use of economic, clinical, and epidemiological evidence, digital health, governance processes and international best practice. He also investigates the role of standards in Australia’s Quality Commissions and identifies the implications for Value Based Health Care. He will also undertake research relating to Australian and international guidelines in Nephrology.
David’s involvement with GENI commenced as a researcher with the management team on ‘Cost Effectiveness of Prostate Cancer screening and diagnostic strategies: International Lessons for Clinical Practice Guidelines’ (2018). He then gained experience in the study concerning ‘Cost Effectiveness Analysis of Child Vaccinations in Africa: International Lessons for Clinical Practice Guidelines in Developing Countries’. He was promoted to senior project manager during December 2019.
David is completing Advanced Training in General Medicine with the Royal College of Physicians (RACP), and currently holds employment as a senior medical registrar at the Royal Melbourne Hospital, Victoria, Australia. Upon completion, he will be qualified as an Acute and General Care Physician. He trained in Adelaide, South Australia, and previously worked with both Southern and Central Local Adelaide Health Networks.
He has a keen interest in education, leading medical education sessions for his colleagues and medical students throughout his career. His prior published research areas have included pharmacology and mental health.
Contact: david.warncken@gmail.com